Predicta Biosciences
PrivateLast Round
Series A
Oct 1, 2025
Total Funding Raised
$28.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Predicta Biosciences is a biotechnology company that has developed an oncology technology platform designed for cancer diagnosis and treatment, specializing in integrating multi-omics and liquid biopsy technologies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Predicta Biosciences Comparables
Compare Predicta Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede | 82% | |
| One Biosciences | 80% | |
| Delfi Diagnostics | 76% |
Predicta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 1, 2025 | ||||
| Seed | Jul 16, 2024 |
Predicta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Seed, Series A |
| Binney Street Capital | Series A |
| Mass General Brigham Innovation | Series A |
| Mass General Brigham Ventures | Series A |
| BrightEdge | Seed, Series A |
| Engine Ventures | Seed, Series A |
| Time Boost Capital I LP | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Grew 33% QoQ, from 15 to 20 employees.
- Apr 15, 2026
Launched GenoPredicta test kit in partnership with Tempus AI.
Predicta Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Predicta Biosciences's valuation, stock price, and market status.
Is Predicta Biosciences a public or private company?
Predicta Biosciences is a private company.
What is the current stock price of Predicta Biosciences?
Predicta Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Predicta Biosciences worth (valuation)?
Valuation information for Predicta Biosciences is not publicly available.
Can I buy Predicta Biosciences stock?
Predicta Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Predicta Biosciences's last funding round?
Predicta Biosciences's most recent funding round was Series A on October 1, 2025.
Who are the main investors in Predicta Biosciences?
Key investors in Predicta Biosciences include Engine Ventures, Engine Ventures.
Will Predicta Biosciences IPO soon?
No public IPO plans have been announced for Predicta Biosciences.
How can I track Predicta Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Predicta Biosciences's secondary market activity and sign up for updates.